"Today we stand poised on the brink of a new era of computing in which technology is more consumable, insight-driven and cognitive", Ginni Rometty, IBM President and CEO .
For decades, our interaction with machines has been dictated by the way they operate. People had to adapt to the manner computers work and not the other way around. Cognitive computing, however, is likely to put those days behind us. In this "new era of computing", the human brain becomes the model after which computer systems are designed.
A growing number of companies are engaged
in the once unimaginable task of
re-engineering the world's most complex computer, the human
Activities within the field of cognitive computing are strong
Enacted in 1981, the federal Research and Development (R&D) Tax Credit allows a credit of up to 13% of eligible spending for new and improved products and processes. Qualified research must meet the following four criteria:
Eligible costs include employee wages, cost
of supplies, cost of testing,
contract research expenses, and costs associated with
developing a patent. On
January 2, 2013, President Obama signed the bill extending the
Credit for 2012 and 2013 tax years.
Manoj Saxena, business manager for IBM's Watson, says that 90% of the world's information was created within the last two years based on the volume of information created by computers and electronic sensors. The rise of "Big Data", defined as large data sets that are too large and complex to be analyzed by conventional means, calls for the development of new ways to process information. Traditional computing systems, limited by aspects such as processor speed and hardware scalability, are no longer good enough.
In this context, a new generation of computing systems emerges, combining technology and biology and using the human brain as inspiration to build machines that are teachable, adaptable, and ultimately, intelligent. Cognitive computing incorporates the concept of neural network that, through the accumulation of knowledge and experience, allows for informed decision making and problem solving. In other words, the circuit of biological neurons of the human brain is reproduced in a series of non-linear statistical data modeling and decision making tools.
General characteristics of this disruptive technology can be summarized as follows :
There has been considerable competition in the field of Big Data, involving both start-ups and major companies, such as Microsoft, Oracle, and SAP. IBM, however, has long been at the forefront of this race, particularly through its pioneering work on cognitive computing. According to the New York Times, the company's Big Data and analytics customers add up to more than 10,000 and its team is constituted of 9,000 business analytics consultants and 400 mathematicians .
An early example of cognitive computing, IBM's Watson has marveled the world since its launching in 2011. Originally created to answer questions on the show Jeopardy!, Watson has consistently outperformed the quiz's former champions. Susan E. Feldman, author of the book "The Answer Machine", highlights four major breakthroughs brought forward by Watson. Firstly, the system integrates a Deep QA Technology, it "creates hypotheses to expand a question into hundreds of queries and then collects the evidence to support or destroy each hypothesis".
Secondly, Watson is able to assimilate and analyze multiple sources of information (including unstructured data) at a scale no human being could ever match. Thirdly, the system presents an outstanding ability to integrate its more than 40 subsystems (such as natural language processing, categorization, search, logic, heuristics, knowledge, and machine learning) when performing its tasks. Lastly, Watson shows significant adaptability, which translates in the capacity to learn from its users and its body of knowledge.
Potential applications and advancements for
the Watson project are endless.
An example is the use of human senses. IBM predicts that by
will touch, see, hear, taste, and smell. For Bernard Meyerson,
of innovation, computers will increasingly move from
manipulating static data
to exploring "the rich world of data processed by humans
through the five
senses". A few early examples include "smelling" computers
that determine air pollution in human centers and image
Predictions point to a not-too-distant future when computers
will be able to
capture the so-called molecular biomarkers in human breath
that identify health
disorders, such as diabetes and epilepsy. They will also be
able to listen to
and interpret a baby's cry, identifying whether it is caused
pain, or tiredness, for instance.
IBM's Watson exemplifies how cognitive computing can change fundamental aspects of human life. In partnership with the Memorial Sloan-Kettering Cancer Center, IBM is developing a Watson-based decision support system for cancer research and treatment. The idea is to increase both the accuracy of diagnosis and the effectiveness of treatments through the use of evidence-based information. Watson's cumulated "knowledge" includes "more than 600,000 pieces of medical evidence, more than two million pages from medical journals and the further ability to search through up to 1.5 million patient records", an amount of data no human doctor's mind can match. When tested for lung cancer diagnoses, the computer's success rate was 90%, compared to an average of 50% for human doctors. One can only imagine how a wider deployment of similar technologies can revolutionize our health care system.
Through the processing of unprecedented amounts of information, cognitive computing technology can not only change the face of medical diagnoses, but also contribute to monitoring and controlling disease transmission. This is particularly true in the case of new strains of highly drug resistant bacteria, the "superbugs". Cognitive computing can use predictive analysis to track and monitor disease transmission through hospitals, nursing homes, and the general population. Big Data multi agent computer modeling can also track a disease's geographic origins and match incidents against possible sources.
Smart sensors, a fundamental aspect of cognitive computing, are another example. Such sensors differ from passive ones in their ability to process information and pick up on patterns that are used to efficiently control systematic operations . Current applications of smart sensors include multiple fields, such as smart building management and consumer technologies. Future advancements are very promising. A telling example is the development of nanobots (equipped with smart sensors), which will theoretically be capable of instantaneously sensing, diagnosing, and treating ailments within the body.
Critical cognitive computing applications,
however, go beyond health care. A
good example is cyber security, one of the most serious
economic and national
security challenges we face as a nation, but according to
President Obama, one
that we as a government or as a country are not adequately
prepared to counter.
Cognitive systems represent a more efficient way to deal with
ever growing complexity. The rising volume of data and the
mobile devices, social networks, and cloud environments make
it impossible to
face security threats through simple secure perimeters. In
Intelligence Security emerges as a means to prevent, detect,
and address system
breaches through continuous monitoring, diagnosing, and
mitigation of threats.
The decreasing size and mounting power of sensors have cleared the path to the development of wearable computerized devices. Smart watches, digital clothing, and eyewear are an emerging reality. Microsoft has recently joined Apple, Samsung, and LG in the race to develop wrist computers. Google's Glass Project, a wearable computer with a head-mounted display, has called the world's attention as it promises to make wearable gadgets mainstream.
Some understand these new technologies as "cognitive
prostheses". Similar to physical prostheses, which are created
to replace, enhance, or
correct certain capabilities, wearable gadgets offer the
potential to improve
human cognitive performance. In the case of smart spectacles,
digitally augmented reality (that could be as simple as the
overlaying of labels and directional arrows) will enhance the
and understanding of the world. More generally speaking,
wearable devices can give people unprecedented capability in
what comes to
information, memory, data analysis, communication, among
fields. According to the research firm Gartner, wearable smart
expected to be a $10 billion industry by 2016.
The human brain is and will certainly remain an unchallengeable model for data processing. However, greatly beneficial advancements have been achieved by drawing inspiration from this complex biological machine. Future applications of cognitive computing are very promising and will most likely constitute a new technological era. Companies engaging in cognitive computing R&D activities may be entitled to significant Federal Tax Credits.
Charles R Goulding Attorney/CPA, is the President of R&D Tax Savers.
Andressa Bonafé is a Tax Analyst with R&D Tax Savers.
Charles G Goulding is a practicing attorney with experience in R&D tax credit projects for a host of industries.
|The R&D Tax Credit Aspects of the 21st Century Cures Act|
|The R&D Tax Credit Aspects of Mechatronics|
|The R&D Tax Credit Aspects of Emotion-Recognition Technology|
|The R&D Tax Credit Aspects of Immunology|
|The R&D Tax Credit Aspects of Arthritis|
|The R&D Tax Credit Aspects of Asthma|
|The R&D Tax Credit Aspects of Telemedicine|
|R&D Tax Credits Enhance Life Science Impact Investing|
|The R&D Tax Credit Aspects of Pediatric Hypertension|
|The R&D Tax Credit Aspects of Parkinsons Disease Technology|
|The R&D Tax Credit Aspects of Legal Medical Marijuana|
|Reaching for the Moon: The R&D Tax Credit Aspects of Conquering Cancer|
|The R&D Tax Credit Aspects of Zika|
|The R&D Tax Aspects of CRISPR-CAS9|
|The R&D Tax Credit Aspects of Bioelectronic Medicine|
|The R&D Tax Credit Aspects of Liquid Biopsy Testing|
|The R&D Tax Credit Aspects of Cryogenics|
|The R&D Tax Aspects of Microbiome Research|
|The R&D Tax Aspects of Mouse Models in Clinical Research|
|The R&D Tax Aspects of Precision Medicine|
|The R&D Tax Aspects of Synthetic Biology|
|The R&D Tax Aspects of Pharmaceutical Packaging|
|New Standards and Regulations Create R&D Tax Credit Opportunities for the Pharmaceutical Packaging Industry|
|The R&D Tax Credit Aspects of Orphan Drugs|
|The R&D Tax Credit Aspects of Blood|
|The R&D Tax Aspects of Regenerative Medicine|
|The R&D Tax Credit Aspects of Environmental Remediation|
|The R&D Tax Credit Aspects of Gastro Technology|
|The R&D Tax Credit Aspects of Multiple Sclerosis|
|The R&D Tax Credit Aspects of the Internet of DNA|
|The R&D Tax Credit Aspects of Concussion Technology|
|The R&D Tax Credit Aspects of Schizophrenia|
|The R&D Tax Aspects of Cancer Treatment|
|The R&D Tax Aspects of the New FDA Mobile Apps Requirements|
|The R&D Tax Credit Aspects of the Medical Software Industry|
|The R&D Tax Aspects of Computer Enabled Human Identification|
|The R&D Tax Credit Aspects of Heart Disease|
|The R&D Tax Credit Aspects of Biological Drugs|
|The R&D Tax Aspects of Respiratory Diseases|
|The R&D Tax Credit Aspects of Cosmetics|
|The R&D Tax Credit Aspects of Major Life Science Benefactors|
|The R&D Tax Credit Aspects of the Health Cloud|
|The R&D Tax Credit Aspects of Autism|
|The R&D Tax Credit Aspects of 3D Bioprinting|
|The R&D Credit Aspects of Cell Therapy|
|The R&D Tax Credit Aspects of Sugar Substitution and Reduction in Food Products|
|The R&D Tax Credit Aspects of Gluten-Free Foods|
|R&D Tax Credit Aspects of Sleep Innovation|
|R&D Tax Credit Aspects of Medical Robotics|
|The R&D Tax Aspects of Neuroscience|
|The R&D Tax Credit Aspects of Hearing Technology|
|The R&D Tax Credit Aspects of Eye Disease|
|The R&D Tax Credit Aspects of Dermatology Innovation|
|The R&D Tax Credit Aspects of Bioinformatics|
|The R&D Tax Aspects of Lab Equipment and Instrumentation|
|The R&D Tax Aspects of Salt Reduction|
|The R&D Tax Aspects of Generic Drugs|
|The R&D Tax Credit Aspects of Novel Uses for Genetically Engineered Organisms|
|R&D Tax Credit Fundamentals|
|R&D Credits for Companies Combating Superbugs|
|The R&D Tax Credit Aspects of Alzheimers|
|The R&D Tax Aspects of Diabetes|
|The R&D Tax Aspects of Brain Mapping|
|R&D Tax Credit Aspects of Human Body Weight|